Canada’s PAAB Releases Draft Guidance on Pharma Advertising Based on Real-World Evidence

The Canadian not-for-profit Pharmaceutical Advertising Advisory Board (PAAB) has just released a draft guidance covering pharma advertising to healthcare professionals (HCPs) based on real-world evidence (RWE). The guidance provides direction on assessing the validity and importance of RWE and the real-world data (RWD) it is derived from when making advertising decisions.

According to Timothy M. Squire, Jean-Raphael Champagne, and Mark Vanderveken, “Under PAAB’s proposed approach outlined in the draft guidance document, RWE may be used in advertising in addition to gold standard data, provided that the RWE data meets certain base requirements for validity and relevance and is presented in the advertisement in alignment with certain formatting principles, each of which is described below.”

To read more, click here.

(Source: Mondaq, April 3^rd, 2023)